Glucocorticoid-resistance/NN
in/IN
peripheral-blood/JJ
lymphocytes/NNS
does/VBZ
not/RB
correlate/VB
with/IN
number/NN
of/IN
affinity/NN
of/IN
glucocorticoid-receptors/NNS
in/IN
chronic/JJ
renal/JJ
failure/NN
patients/NNS
./.

Glucocorticoid/NN
(/(
GC/NN
)/)
resistance/NN
in/IN
patients/NNS
with/IN
chronic/JJ
renal/JJ
failure/NN
(/(
CRF/NN
)/)
seriously/RB
impairs/VBZ
successive/JJ
GC/NN
therapy/NN
after/IN
renal/JJ
transplantation/NN
./.
=====
We/PRP
examined/VBD
the/DT
relationship/NN
between/IN
GC-receptor/NN
(/(
GC-R/NN
)/)
parameters/NNS
in/IN
peripheral-blood/JJ
mononuclear/JJ
cells/NNS
(/(
PBMC/NN
)/)
and/CC
PBMC/NN
resistance/NN
to/TO
GC/NN
in/IN
21/CD
CRF/NN
patients/NNS
and/CC
18/CD
healthy/JJ
subjects/NNS
./.
=====
Each/DT
subject/NN
group/NN
was/VBD
divided/VBN
into/IN
two/CD
subgroups/NNS
according/VBG
to/TO
PBMC/NN
sensitivity/NN
to/TO
prednisolone/NN
in/IN
a/DT
mitogen/NN
assay/NN
procedure/NN
;/:
i.e./FW
,/,
sensitive/JJ
(/(
IC50/NN
</JJR
381/CD
ng/mL/NN
)/)
and/CC
resistant/JJ
(/(
IC50/NN
>/JJR
381/CD
ng/mL/NN
)/)
groups/NNS
./.
=====
In/IN
healthy/JJ
subjects/NNS
,/,
the/DT
mean/NN
GC-R/NN
Bmax/NN
and/CC
Kd/NN
in/IN
quiescent/JJ
PBMC/NN
of/IN
the/DT
GC-sensitive/JJ
group/NN
were/VBD
2.89/CD
+/-/CC
1.23/CD
fmol/10(6)/NN
cells/NNS
and/CC
4.00/CD
+/-/CC
2.24/CD
nM/NN
,/,
respectively/RB
./.
=====
The/DT
Bmax/NN
in/IN
these/DT
subjects/NNS
significantly/RB
increased/VBD
to/TO
6.61/CD
+/-/CC
2.02/CD
(/(
257.7/CD
+/-/CC
107.8/CD
%/NN
)/)
after/IN
24/CD
h/NN
stimulation/NN
with/IN
concanavalin/NN
A/NN
(/(
p/NN
</JJR
0.01/CD
)/)
,/,
while/IN
the/DT
Kd/NN
change/NN
was/VBD
not/RB
significant/JJ
./.
=====
The/DT
GC-R/NN
Bmax/NN
and/CC
Kd/NN
in/IN
quiescent/JJ
PBMC/NN
of/IN
the/DT
GC-resistant/JJ
group/NN
were/VBD
5.33/CD
+/-/CC
1.37/CD
fmol/10(6)/NN
cells/NNS
and/CC
3.20/CD
+/-/CC
1.39/CD
nM/NN
,/,
respectively/RB
./.
=====
Both/DT
of/IN
these/DT
parameters/NNS
,/,
however/RB
,/,
did/VBD
not/RB
change/VB
significantly/RB
after/IN
mitogen/NN
stimulation/NN
./.
=====
There/EX
was/VBD
a/DT
significant/JJ
negative/JJ
correlation/NN
between/IN
IC50S/NN
of/IN
prednisolone/NN
and/CC
increase-ratios/NN
(/(
post/pre/JJ
ratio/NN
)/)
of/IN
Bmax/NN
after/IN
mitogen/NN
stimulation/NN
(/(
p/NN
</JJR
0.05/CD
)/)
./.
=====
In/IN
CRF/NN
patients/NNS
,/,
Bmax/NN
and/CC
Kd/NN
in/IN
quiescent/JJ
PBMC/NN
of/IN
the/DT
GC-sensitive/JJ
group/NN
were/VBD
6.04/CD
+/-/CC
2.35/CD
fmol/10(6)/NN
cells/NNS
and/CC
3.49/CD
+/-/CC
1.72/CD
nM/NN
,/,
respectively/RB
,/,
while/IN
those/DT
in/IN
PBMC/NN
of/IN
the/DT
GC-resistant/JJ
group/NN
were/VBD
5.13/CD
+/-/CC
2.31/CD
fmol/10(6)/NN
cells/NNS
and/CC
4.04/CD
+/-/CC
1.62/CD
nM/NN
,/,
respectively/RB
./.
=====
The/DT
Bmax/NN
and/CC
Kd/NN
were/VBD
not/RB
significantly/RB
changed/VBN
after/IN
mitogen/NN
stimulation/NN
in/IN
both/DT
subgroups/NNS
of/IN
CRF/NN
./.
=====
Moreover/RB
,/,
in/IN
contrast/NN
to/TO
healthy/JJ
subjects/NNS
,/,
there/EX
was/VBD
no/DT
correlation/NN
between/IN
IC50/NN
and/CC
GC-R/NN
parameters/NNS
in/IN
CRF/NN
./.
=====
We/PRP
concluded/VBD
that/IN
,/,
in/IN
healthy/JJ
subjects/NNS
,/,
decreased/VBN
PBMC/NN
capacity/NN
to/TO
amplify/VB
GC-R/NN
numbers/NNS
in/IN
response/NN
to/TO
mitogen/NN
is/VBZ
correlated/VBN
with/IN
GC/NN
resistance/NN
,/,
whereas/IN
in/IN
CRF/NN
patients/NNS
the/DT
resistant/JJ
mechanism/NN
is/VBZ
not/RB
correlated/VBN
with/IN
GC-R/NN
parameters/NNS
./.
=====
An/DT
unknown/JJ
event/NN
might/MD
be/VB
involved/VBN
in/IN
GC-resistance/NN
of/IN
CRF/NN
./.